As is shown in Table 3, the summary estimates of sensitivity, specificity, and AUC for MDK in predicting AFP-negative HCC were 88.5, 83.9%, and 0.91, respectively, indicating that serum MDK can be used as a supplementary method for the diagnosis of HCC, especially for AFP-negative HCC. Here, AFP is linked to hepatocellular carcinoma.